In summary, these results suggest that MTOR mutations and 10q25.3 deletion inhibit cell proliferation, possibly through a same mechanism of modulating mTOR signaling pathway (Fig. 4Q), which provides an explanation for the mutual exclusivity between these frequent genomic aberrations in PDAC patients with the history of diabetes. This evidence concerns the gene MTOR and diabetes mellitus.